Nitroglycerin (Oral extended-release capsule)

Nitroglycerin (Oral extended-release capsule)
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Nitroglycerin (Oral extended-release capsule) is {{{aOrAn}}} {{{drugClass}}} that is FDA approved for the {{{indicationType}}} of {{{indication}}}. Common adverse reactions include {{{adverseReactions}}}.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

There is limited information regarding Nitroglycerin (Oral extended-release capsule) FDA-Labeled Indications and Dosage (Adult) in the drug label.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Nitroglycerin (Oral extended-release capsule) in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Nitroglycerin (Oral extended-release capsule) in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding Nitroglycerin (Oral extended-release capsule) FDA-Labeled Indications and Dosage (Pediatric) in the drug label.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Nitroglycerin (Oral extended-release capsule) in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Nitroglycerin (Oral extended-release capsule) in pediatric patients.

Contraindications

There is limited information regarding Nitroglycerin (Oral extended-release capsule) Contraindications in the drug label.

Warnings

There is limited information regarding Nitroglycerin (Oral extended-release capsule) Warnings' in the drug label.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trials Experience of Nitroglycerin (Oral extended-release capsule) in the drug label.

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Nitroglycerin (Oral extended-release capsule) in the drug label.

Drug Interactions

There is limited information regarding Nitroglycerin (Oral extended-release capsule) Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Nitroglycerin (Oral extended-release capsule) in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Nitroglycerin (Oral extended-release capsule) in women who are pregnant.

Labor and Delivery

There is no FDA guidance on the use of Nitroglycerin (Oral extended-release capsule) during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Nitroglycerin (Oral extended-release capsule) with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Nitroglycerin (Oral extended-release capsule) with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Nitroglycerin (Oral extended-release capsule) with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Nitroglycerin (Oral extended-release capsule) with respect to specific gender populations.

Race

There is no FDA guidance on the use of Nitroglycerin (Oral extended-release capsule) with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Nitroglycerin (Oral extended-release capsule) in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Nitroglycerin (Oral extended-release capsule) in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Nitroglycerin (Oral extended-release capsule) in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance on the use of Nitroglycerin (Oral extended-release capsule) in patients who are immunocompromised.

Administration and Monitoring

Administration

There is limited information regarding Nitroglycerin (Oral extended-release capsule) Administration in the drug label.

Monitoring

There is limited information regarding Monitoring of Nitroglycerin (Oral extended-release capsule) in the drug label.

IV Compatibility

There is limited information regarding the compatibility of Nitroglycerin (Oral extended-release capsule) and IV administrations.

Overdosage

There is limited information regarding Nitroglycerin (Oral extended-release capsule) overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

There is limited information regarding Nitroglycerin (Oral extended-release capsule) Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Nitroglycerin (Oral extended-release capsule) Mechanism of Action in the drug label.

Structure

There is limited information regarding Nitroglycerin (Oral extended-release capsule) Structure in the drug label.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Nitroglycerin (Oral extended-release capsule) in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Nitroglycerin (Oral extended-release capsule) in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Nitroglycerin (Oral extended-release capsule) in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Nitroglycerin (Oral extended-release capsule) in the drug label.

How Supplied

There is limited information regarding Nitroglycerin (Oral extended-release capsule) How Supplied in the drug label.

Storage

There is limited information regarding Nitroglycerin (Oral extended-release capsule) Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Nitroglycerin (Oral extended-release capsule) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Nitroglycerin (Oral extended-release capsule) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Nitroglycerin (Oral extended-release capsule) in the drug label.

Precautions with Alcohol

Alcohol-Nitroglycerin (Oral extended-release capsule) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

®

Look-Alike Drug Names

A® — B®

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.